We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Green, JE, Wrobel, A, Todd, E, Marx, W, Berk, M, Lotfaliany, M, et al.Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry [Epub ahead of print] 11 Dec 2024. Available from: https://doi.org/10.1192/bjp.2024.121.Google ScholarPubMed
2
Collins, JM, Cryan, JF, OMahony, SM. Importance of the microbiota in early life and influence on future health. In The Gut-Brain Axis 2nd ed (eds Hyland, N, Stanton, C): 37–76. Academic Press, 2024.CrossRefGoogle Scholar
3
Loh, JS, Mak, WQ, Tan, LK, Ng, CX, Chan, HH, Yeow, SH, et al.Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther2024; 9(1): 37.CrossRefGoogle ScholarPubMed
Volkova, A, Ruggles, K, Schulfer, A, Gao, Z, Ginsberg, SD, Blaser, MJ.Effects of early-life penicillin exposure on the gut microbiome and frontal cortex and amygdala gene expression. iScience2021; 24(7): 102797.CrossRefGoogle ScholarPubMed
6
Choi, A, Lee, H, Jeong, HE, Lee, S-Y, Kwon, JS, Han, JY, et al.Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population-based cohort study. BMJ2024; 385: e076885.CrossRefGoogle ScholarPubMed
7
Slykerman, RF, Neumann, D, Underwood, L, Hobbs, M, Waldie, KE.Age at first exposure to antibiotics and neurodevelopmental outcomes in childhood. Psychopharmacology2023; 240(5): 1143–50.CrossRefGoogle ScholarPubMed
8
Bicknell, B, Liebert, A, Borody, T, Herkes, G, McLachlan, C, Kiat, H.Neurodegenerative and neurodevelopmental diseases and the gut-brain axis: the potential of therapeutic microbiome targeting. Int J Mol Sci2023; 24(11): 9577.CrossRefGoogle Scholar
9
Volker, E, Tessier, C, Rodriguez, N, Yager, J, Kozyrskyj, A.Pathways of atopic disease and neurodevelopmental impairment: assessing the evidence for infant antibiotics. Exp Rev Clin Immunol2022; 18(9): 901–22.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.